Why Donor Supply Chains May Decide the Future of Cell Therapy Commercialisation

As cell and gene therapies advance toward commercial reality, the industry's focus is rapidly shifting beyond manufactur...

June 15, 2026 | Monday | News
MaaT Pharma Reports Phase 3 Data for Microbiome Therapy in Acute GvHD

MaaT Pharma has presented final Phase 3 data from the ARES pivotal trial evaluating MaaT013 in acute graft-versus-host d...

June 11, 2026 | Thursday | News
Sanofi Secures EU Approval for Subcutaneous Sarclisa in Multiple Myeloma

Sanofi has received European Commission approval for subcutaneous Sarclisa, or isatuximab, in combination with standard-...

June 10, 2026 | Wednesday | News
Argo Biopharma to Present Updated Phase II Data for siRNA HAE Therapy at EAACI 2026

Argo Biopharma will present updated Phase II results for BW-20805, its investigational siRNA therapy for hereditary angi...

June 9, 2026 | Tuesday | News
VERTANICAL Secures First European Marketing Authorisation for Exilby in Chronic Low Back Pain

VERTANICAL has received marketing authorisation in Germany for Exilby, or VER-01, for the treatment of chronic low back ...

June 9, 2026 | Tuesday | News
Hansa Biopharma Reports Positive European Post-Authorisation Data for Idefirix

Hansa Biopharma has reported positive topline results from a European post-authorisation efficacy study of Idefirix in h...

June 8, 2026 | Monday | News
Amgen Receives EC Approval for IMDYLLTRA in Extensive-Stage Small Cell Lung Cancer

Amgen has received European Commission marketing authorisation for IMDYLLTRA, or tarlatamab, as monotherapy for adults w...

June 5, 2026 | Friday | News
AbbVie Secures EC Approval for AQUIPTA as Acute Migraine Treatment

AbbVie has received European Commission approval for AQUIPTA, or atogepant, as an acute treatment for migraine in adults...

June 5, 2026 | Friday | News
Henlius and Organon Secure EC Approval for First Pertuzumab Biosimilar in Europe

Shanghai Henlius Biotech and Organon have received European Commission marketing authorisation for POHERDY, a pertuzumab...

June 4, 2026 | Thursday | News
Omnix Medical Announces First Patients Dosed in Phase II Trial of Antimicrobial Lead Compound OMN6

Omnix Medical, a biopharmaceutical company developing next-generation anti-infectives for severe multidrug-resistant inf...

June 4, 2026 | Thursday | News
Enbiosis Biotechnology unveils proprietary nutraceutical formulation engine Enbiosis 2.0

Artificial intelligence (AI) has reshaped drug discovery, diagnostics, and genomics. The nutraceutical sector has been s...

May 27, 2026 | Wednesday | News
Hong Kong's Cornerstone Robotics receives European Union CE mark

Cornerstone Robotics (CSR), a leading global innovator in surgical robotics based in Hong Kong, China, has announced tha...

May 25, 2026 | Monday | News
AUTOMA+ 2026: Practical Digitalisation for Industrial Pharma

Most pharma digitalisation projects never leave the pilot stage. AUTOMA+ 2026 is built for the ones that do. Fragmented ...

May 18, 2026 | Monday | News
Vetter starts construction of new facility in Germany for production of injectable drugs

Vetter, a leading Contract Development and Manufacturing Organization (CDMO), has announced the start of constructi...

May 14, 2026 | Thursday | News
Thermo Fisher sells microbiology biz to Astorg for $1.075 B

US-based Thermo Fisher Scientific Inc. has signed a definitive agreement to sell its microbiology business to Astorg, a ...

April 28, 2026 | Tuesday | News
CEPI and Pasteur Network partner to advance regional vaccine R&D

Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and the Pasteur Network (PN), in Paris, have signed ...

April 24, 2026 | Friday | News
Merck Launches Bio Based Solvent Portfolio For High Performance Liquid Chromatography

Merck Launches First Bio-Based Solvent Portfolio for High-Performance Liquid Chromatography   Solvents made fro...

April 23, 2026 | Thursday | News
Freudenberg Medical launches ISO Class 5 controlled cleanroom for sterile single-use assemblies

Germany-based Freudenberg Medical, a global contract design and manufacturing partner to the medical device and bio...

April 20, 2026 | Monday | News
Almirall and Barcelona Supercomputing Center expand collaboration to accelerate innovation in medical dermatology

Almirall, S.A. (ALM), a global biopharmaceutical company dedicated to medical dermatology, has announced an expanded col...

April 13, 2026 | Monday | News
Australian startup 4DMedical receives CE Mark to launch respiratory imaging technology in Europe

Australia-based startup 4DMedical has announced that its latest imaging technology, CT:VQ™ has received CE Mark ce...

March 31, 2026 | Tuesday | News
Roche inaugurates new research home for Institute of Human Biology

Roche has announced the inauguration of the new research home for the Institute of Human Biology (IHB). The opening mark...

March 26, 2026 | Thursday | News
Japan's Fujifilm invests in Valanx Biotech to strengthen ADC CDMO capabilities

Japan-based Fujifilm Corporation has announced its investment in Valanx Biotech, an Austrian biotechnology company with ...

March 18, 2026 | Wednesday | News
PROCEPT BioRobotics® expands global footprints of its AI-Enabled Aquablation® Therapy

PROCEPT BioRobotics announced the international expansion of the HYDROS Robotic System, the company’s next-generat...

March 13, 2026 | Friday | News
Predictive Monitoring Advances Cold Storage Resilience In Biopharma Facilities

Cold storage infrastructure plays a critical role across the life sciences industry, safeguarding vaccin...

March 12, 2026 | Thursday | News
Digital Manufacturing Must Lead The Next Phase Of Cell And Gene Therapy Scale Up

In conversation with Ankit Kankar, General Manager at BioSpectrum Asia, Alexander Seyf, CEO and co found...

March 12, 2026 | Thursday | News